AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05302219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tidal volume
Description: The participant alternates tidal volumes of approx. 2, 1 and 0.5 litres. Breathe each tidal volume for 2 minutes with a one-minute break.
Study NCT04691778 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CTO PCI with the first-choice Gladius guidewire
Description: CTO PCI using antegrade wiring strategy with the first-choice Gladius guidewire
Study NCT04691778 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: CTO PCI without the first-choice Gladius guidewire
Description: CTO PCI using standard antegrade wire escalation strategy
Study NCT03384537 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Listerine total care zero
Description: reducing intra-oral cariogenic microorganism.
Study NCT03384537 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine Mouthwash (0.2%).
Description: Chlorhexidine Mouthwash (0.2%).
Study NCT05302219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apnea
Description: The participant simulates three apneic pauses lasting 1 minute with a two-minute break.
Study NCT05095649 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Regulatory T-cell enriched infusion
Description: Enrichment of cluster of differentiation 25hi regulatory T cells from cluster of differentiation antigen 8 and/or cluster of differentiation antigen19 pre-depleted leukapheresis products.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Administered orally.
Study NCT06424873 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET/CT with FDG or FES
Description: The study consists of an additional 50 minutes of imaging during the radiotracer's uptake phase prior to their clinical scan (standard of care).
Study NCT03798145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Retinotomy
Description: Surgical removal of small areas of retinal to increase outflow through the posterior drainage pathway.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone
Description: Administered orally.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abiraterone
Description: Administered orally.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone or Prednisolone
Description: Administered orally.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone or Prednisolone
Description: Administered orally.
Study NCT05288166 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for Abemaciclib
Description: Administered orally.
Study NCT05472896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cTACE
Description: transcatheter arterial chemoembolization with
Study NCT05968456 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Observational study in patients undergoing thoracic, cardiac and vascular surgery.
Study NCT04417777 — intervention group
Intervention type: GENETIC
Intervention: Blood Test
Description: Blood analysis
Study NCT05472896 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cTACE
Description: transcatheter arterial chemoembolization with
Study NCT05472896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dicycloplatin (TP21)
Description: the dosage of dicycloplatin was based on the body surface area (550 mg/m2) according to previous research. The volume ratio of lipiodol to dicycloplatin aqueous solution was 1:1. The volume of lipiodol used was calculated by the size and vascularity of the tumor, within 20 mL.
Study NCT05472896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: the dosage of epirubicin was determined according to the tumor size, and the maximum dose was limited to 40 mg. The volume ratio of lipiodol to epirubicin aqueous solution was 2:1. The volume of lipiodol used was calculated by the size and vascularity of the tumor, within 20 mL.
Study NCT05746130 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plastic-free diet program
Description: Applying the plastic-free diet as four meals (three main meals, one snack) in pension kitchen. Promoting of glass water bottle giving and daily use.~Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample.
Study NCT05746130 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Plastic-free diet education program
Description: Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample
Study NCT05746130 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plastic-free diet education program
Description: Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample
Study NCT05746130 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BPA exposure feedback
Description: Feedback about BPA levels in theirs urinary sample
Study NCT05746130 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BPA exposure feedback
Description: Feedback about BPA levels in theirs urinary sample
Study NCT05331391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief mobile SMART Exercise Support Program
Description: Patients will receive 1) a brief SMART Exercise individual face-to-face session; 2) a theory-based instant messaging (WhatsApp/WeChat) and telephone-delivered health coaching on a 2-stage tapering schedule. Stage 1 (week 1 to 6): daily messages and two biweekly phone calls for exercise habit formation. Stage 2 (week 7 to 12): messages twice a week and monthly phone calls for exercise habit maintenance.
Study NCT05331391 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Brief mobile SMART Exercise Support Program
Description: Patients will receive 1) a brief SMART Exercise individual face-to-face session; 2) a theory-based instant messaging (WhatsApp/WeChat) and telephone-delivered health coaching on a 2-stage tapering schedule. Stage 1 (week 1 to 6): daily messages and two biweekly phone calls for exercise habit formation. Stage 2 (week 7 to 12): messages twice a week and monthly phone calls for exercise habit maintenance.
Study NCT06427187 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: an array of devices are used in thrombectomy. These include guide catheters, stent-retrievers, microcatheters, aspiration catheters, and aspiration pump systems
Description: each patient with distal vessel occlusion subjected to mechanical thrombectomy using aspiration technique or stent retriever
Study NCT05829850 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SYNOLIS VA 40/80
Description: Three 2mL injections of SYNOLIS VA 40/80, one week apart
Study NCT05093881 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cellgram-LC
Description: Patients who had administered Cellgram-LC in PMC-P-07 study
Study NCT04974619 — intervention group
Intervention type: BEHAVIORAL
Intervention: Online survey
Description: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Study NCT04922216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Diet Monitoring
Description: Standard monitoring using smartphone tracking of all calorie intake.
Study NCT05170464 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acute Exercise
Description: Brisk walking on a treadmill at ⅔ maximum heart rate as defined by 220-age (in years).
Study NCT05170464 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine Powder
Description: Participants will receive powdered caffeine dissolved in one cup of water (1.2mg/kg)
Study NCT05969808 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: baseline therapy and conventional therapy
Description: These activities included were warm-up activities, general playtime, basic gross motor activities, and free play with toys three times a week for 45 minutes for a period of 12 weeks.
Study NCT05969808 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: baseline treatment and adaptive physical activity
Description: The experimental group's intervention plan had the following 12 elements . Each of which was completed for 10 minutes with two-minute breaks. Warm-up activities, puzzles and manipulatives, e.g., interlocking blocks or shape sorting toys, Balloon Badminton, Obstacle course (crawl in Tunnel ), Peg board play, Tactile sensory bin exploration filled with sand, Ball roll and catch, Tracing shapes, Play dough and clay activities, Cutting and pasting.
Study NCT05488171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylone
Description: Single oral dose of 200 mg of methylone.
Study NCT05488171 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3,4-methylenedioxymethamphetamine
Description: Single oral dose of 100 mg of MDMA.
Study NCT05488171 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single oral dose of placebo.
Study NCT06558487 — intervention group
Intervention type: OTHER
Intervention: Cancer Admission Score Prediction Model
Description: A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results
Study NCT05058716 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood sample
Description: weekly blood sample - coenzym q10 levels
Study NCT05747599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention with contingent incentives and text-based support
Description: Contingent incentives on abstinence from alcohol, tobacco, and cannabis; Text-based support based on educational components
Study NCT05747599 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intervention with contingent incentives and text-based support
Description: Contingent incentives on abstinence from alcohol, tobacco, and cannabis; Text-based support based on educational components
Study NCT05997654 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MEDGEL ANTIAGE
Description: The MEDGEL ANTIAGE is a medical grade silicone plate, biocompatible.
Study NCT05541757 — intervention group
Intervention type: DRUG
Intervention: In vitro heparin
Description: In vitro heparin and in vitro LMWH
Study NCT04974619 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus groups or Individual Interviews
Description: Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
Study NCT04974619 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interviews
Description: In-depth interviews (n=20) will be conducted with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
Study NCT06073899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Leg Extension Exercise
Description: Participants will perform a concentric quadriceps contraction into terminal knee extension with weight equivalent to 65% of a1-repetition maximum.
Study NCT06073899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Leg Extension Exercise
Description: Participants will perform a concentric quadriceps contraction into terminal knee extension with weight equivalent to 65% of a1-repetition maximum.
Study NCT06227377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QTX3034
Description: QTX3034 will be administered at protocol defined dose
Study NCT06227377 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab will be administered at protocol defined dose.
Study NCT05920161 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Socially Evaluated Cold Pressor Test
Description: The SECPT is a brief validated laboratory-based stress induction containing both physical and social elements
Study NCT05920161 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: This is matched to the SECPT but with warm instead of cold water
Study NCT05260034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FAST Program
Description: This program aims to teach how to effectively reduce impact forces during a sideways fall by 1) changing the trunk/knee angles during descent to decrease body acceleration, 2) using a rolling movement to allow for an optimal distribution of impact forces applied to any site along the contact path; and 3) tucking the chin to protect the head.
Study NCT05260034 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Otago Exercise Program
Description: The Otago Exercise Program (OEP) was chosen, rather than no control intervention, to increase the level of evidence required to demonstrate efficacy, and because, similar to the safe fall training used here, it was designed to be performed individually or in small groups.
Study NCT04922216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simplified Diet Monitoring
Description: Simplified diet monitoring using smartphone tracking of red foods using a traffic light approach.
Study NCT06441656 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vitrectomy with ILM flap
Description: In both groups, a single-layer ILM temporal flap of approximately 2 times the size of the optic disc was fashioned using an ILM forceps temporal to the macula. The nasal edge of the flap was not detached from the temporal MH edge. The flap was reflected nasally to cover the MH
Study NCT06441656 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vitrectomy with ILM flap
Description: In both groups, a single-layer ILM temporal flap of approximately 2 times the size of the optic disc was fashioned using an ILM forceps temporal to the macula. The nasal edge of the flap was not detached from the temporal MH edge. The flap was reflected nasally to cover the MH
Study NCT04785248 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Three-step disinfection
Description: Three step disinfection method can be divide in three part. The first step of disinfection: scalp dandruff removal + disinfection The second step of disinfection: whole head Use 2% iodine tincture to smear the whole head skin, the assistant helps to lift the head to expose the surgical field, from both eyebrows to the occipital hairline, from both sides to the neck, after the iodine tincture dry out, use 75% alcohol to deionize. Then placing more than 4 layers of operation towel under the head.~The third step of disinfection: neck chest abdomen disinfection.
Study NCT06142292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual counseling
Description: Individual counseling sessions with a licensed mental health counselor
Study NCT06142292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group counseling
Description: Group counseling sessions with a licensed mental health counselor
Study NCT06101550 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: partial pulpotomy
Description: Partial removal of pulp tissue in young permanent teeth
Study NCT06101550 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete pulpotomy
Description: Complete removal of pulp tissue in young permanent teeth
Study NCT06494124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial Alternating current stimulation (tACS)
Description: It is a non-invasive brain stimulation technique that uses small, pulsed alternating current (1mA) to modulate lasting cortical excitability, producing facilitatory or inhibitory effects upon a variety of behaviours, with proven efficacy in various neuropsychiatric disorders.
Study NCT06494124 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial Direct current stimulation (tDCS)
Description: It is a non-invasive brain stimulation technique that uses constant, low direct current to modulate lasting cortical excitability, producing facilitatory or inhibitory effects upon a variety of behaviours, with proven efficacy in various neuropsychiatric disorders.
Study NCT06494124 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham controlled
Description: 1mA current will be applied for the first 30 seconds to provide the initial sensation of real stimulation, and then the current will be stopped, thus minimizing the stimulatory effects. It is known to have no effect on psychopathology/neuro-cognition and means to mimic the tDCS/tACS (in order to help blinding of the participants).
Study NCT06343584 — intervention group
Intervention type: OTHER
Intervention: Study will conducted over a six-month period using a quasi-experimental Pre-test/Post-test design using Stamm's (2009) ProQOL Scale.
Description: Group 1 will receive a list of suggested tools used to decrease the amount of smartphone interruptions after business hours (Appendix B) and Group 2 will receive a work-issued smartphone with instructions for use (Appendix C). Both groups will use a pre-post test format designed to compare the outcomes between the two groups. Post-study analysis will compare pre- and post-tests within each group and will compare Group 1 and Group 2 post-intervention outcomes.
Study NCT04540692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel or Paclitaxel
Description: Treatment will start with Docetaxel 75-100mg/m² intravenously every 21 days for 4 cycles or weekly paclitaxel 80mg/m² for 12 weeks
Study NCT04540692 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide + Doxorrubicin
Description: Treatment will start with Doxorubicin 60mg/m²; Cyclophosphamide 600mg/m² intravenously every 21 days for 3 cycles
Study NCT04674150 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ARISE with AR
Description: An augmented reality game for mobile devices with AR experiences enabled
Study NCT04674150 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: ARISE without AR
Description: An augmented reality game for mobile devices with AR experiences disabled as an control
Study NCT05683782 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Split thickness Apically positioned flap with Chitosan based Erythropoietin Gel application
Description: Split thickness Apically positioned flap will be performed to increase width of attached gingiva .1 mL of EPO-loaded with chitosan 5% and β-glycerophosphate disodium salt (GP) 20% gel will be used by the patient two times daily for 14 days.
Study NCT05683782 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Split thickness Apically positioned flap without Erythropoietin application
Description: Split thickness Apically positioned flap will be performed to increase width of attached gingiva.The patient will use a Chitosan gel without being loaded with erythropoietin two times daily for 14 days
Study NCT06535555 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational Safety and Feasibility
Description: Technical feasibility will be assessed based on a five-point rating scale assessing the ease-of-use, ureteral visibility, and time required to identify the ureter using ActivSight™. All images and video of the ureter will be recorded, but surgeon feedback will be used to assess technical success based on a five point scale, rather than these (subsequently de-identified) recordings.~Safety will be confirmed through clinical assessments and evaluation of adverse events intraoperatively and through a 28-day follow-up period using the criteria listed below. All adverse events will be adjudicated by the site's Principal Investigator (PI) to judge the relatedness of the adverse event to either the administration of riboflavin or the use of the prototype ActivSight™ device (or whether the adverse event was unrelated to either)
Study NCT05429489 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilevel erector spinae plane block
Description: Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels
Study NCT05429489 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single level erector spinae plane block
Description: Single level erector spinae plane block at 5th thoracic vertebrae
Study NCT05429489 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous morphine
Description: Intravenous morphine 0.1 mg/kg
Study NCT06118229 — intervention group
Intervention type: DEVICE
Intervention: Wearable smart devices and PROs
Description: Patients wearing wearable smart devices to monitor physiological data while regularly utilizing PROs to report subjective assessments of their own health status.
Study NCT04922216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.